- Home
- ETG vs TXG Comparison
ETG vs TXG Comparison
Compare ETG & TXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETG
- TXG
- Stock Information
- Founded
- ETG 2003
- TXG 2012
- Country
- ETG United States
- TXG United States
- Employees
- ETG N/A
- TXG N/A
- Industry
- ETG Investment Managers
- TXG Biotechnology: Laboratory Analytical Instruments
- Sector
- ETG Finance
- TXG Industrials
- Exchange
- ETG Nasdaq
- TXG Nasdaq
- Market Cap
- ETG 1.5B
- TXG 1.3B
- IPO Year
- ETG N/A
- TXG 2019
- Fundamental
- Price
- ETG $21.04
- TXG $14.11
- Analyst Decision
- ETG
- TXG Buy
- Analyst Count
- ETG 0
- TXG 12
- Target Price
- ETG N/A
- TXG $14.13
- AVG Volume (30 Days)
- ETG 132.1K
- TXG 3.7M
- Earning Date
- ETG 01-01-0001
- TXG 08-07-2025
- Dividend Yield
- ETG 6.64%
- TXG N/A
- EPS Growth
- ETG N/A
- TXG N/A
- EPS
- ETG N/A
- TXG N/A
- Revenue
- ETG N/A
- TXG $624,662,000.00
- Revenue This Year
- ETG N/A
- TXG N/A
- Revenue Next Year
- ETG N/A
- TXG $5.69
- P/E Ratio
- ETG N/A
- TXG N/A
- Revenue Growth
- ETG N/A
- TXG N/A
- 52 Week Low
- ETG $14.08
- TXG $6.78
- 52 Week High
- ETG $18.34
- TXG $24.76
- Technical
- Relative Strength Index (RSI)
- ETG 59.15
- TXG 68.91
- Support Level
- ETG $20.64
- TXG $11.45
- Resistance Level
- ETG $21.17
- TXG $14.16
- Average True Range (ATR)
- ETG 0.18
- TXG 0.71
- MACD
- ETG -0.04
- TXG 0.08
- Stochastic Oscillator
- ETG 59.55
- TXG 93.01
About ETG Eaton Vance Tax-Advantaged Global Dividend Income Fund of Beneficial Interest
Eaton Vance Tax Advgd Gbl Div Inc Fd is a diversified, closed-end management investment company. Its investment objective is to provide a high level of after-tax total return consisting of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of aerospace and defense, capital markets, diversified telecommunication services, electrical equipment, biotechnology, banks, and other areas.
About TXG 10x Genomics Inc.
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).